BRIEF-Eyegate Pharmaceuticals reports positive top-line data

* Eyegate announces positive top-line data from phase 1B/2A

clinical trial of EGP-437 for treatment of post-operative

inflammation and pain in cataract surgery patients

Source text for Eikon:

Further company coverage:

Read more